ExitValue.ai

What Is Your Healthcare Staffing Agency Worth?

SMB agencies typically trade at 4-7x EBITDA. Mid-market platforms with credentialing scale and recurring MSP contracts command 6-10x. Travel nursing, locum tenens, and allied health each price differently.

Value Your Healthcare Staffing Business
4-7x
SMB EBITDA Multiple
6-10x
Mid-Market EBITDA
5-8x
Public Comp Range
Consolidating
Market Trend

Live Healthcare Staffing M&A Activity

8
Recent transactions tracked
4 closed in 2024+
5.314.8×
EV/EBITDA range (P25–P75)
Median 9.8×
$343.8M
Median deal size
Most deals are larger than SMB
25% / 50%
PE / Strategic split
Of identified buyers

Aggregated from our database of completed transactions (2020+) — individual deal names included in the gated valuation report.

How Healthcare Staffing Agencies Are Valued

I've worked on healthcare staffing deals across nurse staffing, locum tenens, and allied health travel, and I can tell you the multiple range tells you almost nothing without knowing the modality, the contract mix, and the credentialing infrastructure behind the P&L. A travel nursing agency at $20M revenue is not the same business as a permanent placement firm at $20M revenue, and buyers price them very differently.

The Three Modality Tiers

Per-diem and travel nursing is the highest-volume, lowest-margin segment. Gross margins typically run 18-25%, EBITDA margins land at 6-10% in normal conditions. SMB agencies in this segment trade at 4-6x EBITDA in a normalized environment. The COVID-era multiples of 8-12x were an anomaly driven by crisis-rate billing — anyone using 2021-2022 comps to value a travel nursing agency today is going to be sorely disappointed.

Locum tenens sits in the middle. Physician placement carries higher bill rates, longer assignments, and stickier customer relationships. EBITDA margins often reach 12-18%. SMB locum agencies trade at 5-8x EBITDA, mid-market platforms at 7-10x.

Permanent placement and executive search is the highest-margin tier because there's no contract labor cost flowing through the income statement — it's pure fee revenue. EBITDA margins of 25-40% are common. Multiples reflect this: 6-9x EBITDA at the SMB level, 8-12x for mid-market firms with established healthcare verticals.

Public Comps and What They Tell Us

Cross Country Healthcare (CCRN) typically trades at 4-6x EBITDA, AMN Healthcare (AMN) at 5-8x, and Heidrick & Struggles (HSII) — a relevant comp for the executive search side — at 7-10x. The publics are a useful anchor but they trade at a discount to private deals because they carry travel nursing exposure and lack the take-private control premium.

More relevant for SMB sellers: PE consolidators like Aya Healthcare, Medical Solutions, ALL Medical, and IntelyCare have been actively rolling up regional staffing platforms. The bid range on a $5-25M EBITDA agency with clean credentialing infrastructure and an MSP/VMS contract book has been 6-9x in 2024-2025 deals I've been close to.

Key Value Drivers I Look For

Credentialing infrastructure is the moat. A staffing agency without a scaled credentialing operation is essentially a brokerage. Buyers pay a premium for agencies that have automated primary source verification, ongoing competency tracking, and documented JCAHO/Joint Commission certification. This is the difference between a 5x and a 7x multiple on the same EBITDA.

MSP/VMS contract concentration cuts both ways. A long-term Managed Service Provider contract with a major hospital system gives revenue visibility, but if 40%+ of revenue runs through one MSP, buyers will discount aggressively. The sweet spot is multiple MSP relationships with no single contract above 20% of revenue.

Recruiter productivity and retention drive everything in this business. Buyers will diligence revenue per recruiter, average tenure, and the number of active credentialed clinicians on file. An agency with 200 recruiters generating $400K each and an 18-month average tenure is a fundamentally different asset than one with 400 recruiters generating $200K each at 9-month tenure.

Allied health diversification commands a premium. Agencies that have built out therapy (PT/OT/SLP), imaging tech, and lab tech books alongside nursing trade at higher multiples because they're less exposed to nurse-rate compression cycles.

What Decreases Healthcare Staffing Value

1099 vs W-2 classification risk is the single biggest deal-killer I see in diligence. Agencies that classify clinicians as 1099 contractors face material AB-5 and DOL exposure. Buyers either walk or demand a $2-5M holdback against the liability.

Travel nursing concentration is now a discount, not a premium. Post-COVID normalization has cut crisis-rate billing 40-60%. An agency that built a $50M revenue base on $200/hr crisis bill rates is being valued today on the $80-110/hr normalized rate.

Owner-operator dependency matters more in staffing than most service businesses because so many client relationships sit with the founder. If the owner personally controls the top 5 hospital relationships, expect a 1-2x multiple haircut and an aggressive earnout structure.

Want to know what your healthcare staffing business is worth?

Our calculator uses real M&A transaction data — not generic estimates.

Get Your Valuation Estimate

Frequently Asked Questions

How much does a healthcare staffing agency sell for?

SMB healthcare staffing agencies typically sell for 4-7x EBITDA, with mid-market platforms commanding 6-10x. A $2M EBITDA travel nursing agency might trade at $10-14M, while a $2M EBITDA locum tenens or executive search firm could reach $14-18M. Modality, credentialing infrastructure, and MSP contract mix drive the spread.

What multiple do PE buyers pay for healthcare staffing?

Private equity consolidators like Aya, Medical Solutions, and IntelyCare have been paying 6-9x EBITDA for clean SMB agencies with credentialing scale and diversified MSP relationships. Platform deals (where the agency becomes the PE firm's flagship investment in the space) can reach 9-11x. Add-on acquisitions to existing platforms typically come in at 5-7x.

Why are travel nursing valuations down from 2022 levels?

COVID-era crisis-rate billing created artificially inflated EBITDA across travel nursing in 2021-2022. Bill rates of $180-220/hr have normalized to $80-120/hr, cutting EBITDA materially. Buyers now apply 2024+ run-rate EBITDA, not trailing 2-year averages. Agencies that built revenue on crisis rates are seeing 30-50% lower enterprise values than they would have at peak.

Is permanent placement worth more than per-diem staffing?

Yes — meaningfully. Permanent placement carries 25-40% EBITDA margins versus 6-10% for travel/per-diem because there's no contract labor cost flowing through the P&L. Multiples reflect this: permanent placement firms trade at 6-9x EBITDA SMB and 8-12x mid-market, versus 4-6x for travel-heavy agencies.

What credentialing infrastructure do buyers look for?

Buyers want to see automated primary source verification, ongoing competency tracking, documented compliance with Joint Commission standards, and a scalable platform (typically a system like Bullhorn, Avionté, or a custom-built ATS). Agencies running credentialing on spreadsheets and manual processes get discounted heavily — buyers know they'll need to spend $1-3M to bring it to standard post-close.

How do MSP/VMS contracts affect valuation?

Long-term Managed Service Provider contracts provide revenue visibility, but concentration is a problem. The sweet spot is 5-10 MSP relationships with no single contract exceeding 20% of revenue. Agencies above 40% concentration in one MSP face 1-2x multiple discounts. Agencies with diversified MSP/VMS books at 15-20% concentration each get full multiples.

How long does it take to sell a healthcare staffing agency?

A well-prepared SMB staffing agency typically sells within 6-9 months from engagement to close. Mid-market deals run 9-12 months. The big gating items are 1099 classification cleanup, credentialing system documentation, and MSP contract assignment consents. Agencies with W-2 workforces and clean credentialing run 30-40% faster.

Ready to See What Your Business Is Worth?

Backed by 25,592 verified M&A transactions.

Start Your Valuation